ZA898824B - Aqueous ophthalmic solutions and method for preserving same - Google Patents

Aqueous ophthalmic solutions and method for preserving same

Info

Publication number
ZA898824B
ZA898824B ZA898824A ZA898824A ZA898824B ZA 898824 B ZA898824 B ZA 898824B ZA 898824 A ZA898824 A ZA 898824A ZA 898824 A ZA898824 A ZA 898824A ZA 898824 B ZA898824 B ZA 898824B
Authority
ZA
South Africa
Prior art keywords
chlorine dioxide
stabilized chlorine
ophthalmic solutions
solutions
ophthalmic
Prior art date
Application number
ZA898824A
Other languages
English (en)
Inventor
Anthony J Dziabo Jr
J Dziabo Anthony Jr
Paul S Ripley
S Ripley Paul
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23062361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA898824(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of ZA898824B publication Critical patent/ZA898824B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/10—Halogens or compounds thereof
    • A61L12/102—Chlorine dioxide (ClO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Audible-Bandwidth Dynamoelectric Transducers Other Than Pickups (AREA)
  • Fats And Perfumes (AREA)
ZA898824A 1988-11-29 1989-11-20 Aqueous ophthalmic solutions and method for preserving same ZA898824B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27779188A 1988-11-29 1988-11-29

Publications (1)

Publication Number Publication Date
ZA898824B true ZA898824B (en) 1990-08-29

Family

ID=23062361

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898824A ZA898824B (en) 1988-11-29 1989-11-20 Aqueous ophthalmic solutions and method for preserving same

Country Status (20)

Country Link
US (1) US5424078A (da)
EP (1) EP0371728B1 (da)
JP (1) JP2820744B2 (da)
KR (1) KR0160443B1 (da)
CN (1) CN1055874A (da)
AT (1) ATE147230T1 (da)
AU (1) AU621689B2 (da)
CA (1) CA2003198C (da)
DE (1) DE68927631T2 (da)
DK (1) DK593989A (da)
ES (1) ES2098226T3 (da)
FI (1) FI895700A0 (da)
HK (1) HK1005164A1 (da)
HU (1) HU206455B (da)
IE (1) IE81090B1 (da)
IL (1) IL92351A (da)
NO (1) NO894740L (da)
NZ (1) NZ231458A (da)
PT (1) PT92453B (da)
ZA (1) ZA898824B (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997626A (en) * 1990-01-05 1991-03-05 Allergan, Inc. Methods to disinfect contact lenses
WO1994013332A1 (en) * 1992-12-17 1994-06-23 Allergan, Inc. Contact lens disinfecting solution containing sodium chlorite and polyvinyl pyrrolidone
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
WO2000012137A1 (en) * 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
MXPA01003507A (es) * 1998-10-08 2002-06-26 Hampar L Karagoezian Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US8858961B2 (en) * 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2002242111A1 (en) 2001-02-09 2002-08-28 Bioxy, Inc. Frozen biocidal compositions and methods of use thereof
US7176005B2 (en) * 2002-02-04 2007-02-13 The Regents Of The University Of California Modulation of sulfate permease for photosynthetic hydrogen production
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
CA2505836C (en) * 2004-05-06 2013-08-27 Alcon Inc. Topical brimonidine tartrate formulations that lack chlorine dioxide
MXPA06013649A (es) 2004-05-25 2007-07-09 Sansrosa Pharmaceutical Dev In Compuestos, formulaciones, y metodos para tratar o prevenir desordenes inflamatorios de la piel.
US20050276867A1 (en) 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US7960447B2 (en) * 2006-04-13 2011-06-14 Bausch & Lomb Incorporated Cationic end-capped siloxane prepolymer for reduced cross-link density
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
AU2007304996B2 (en) * 2006-09-28 2013-03-21 Novartis Ag Self-preserved aqueous pharmaceutical compositions
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado
EP2230910A4 (en) 2007-12-21 2011-04-13 Galderma Lab Inc PRE-SURGICAL TREATMENT
ES2443548T5 (es) * 2008-03-17 2020-01-23 Alcon Res Ltd Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
US20100015252A1 (en) 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth Polishing Compositions and Methods of Tooth Polishing Without Mechanical Abrasion
KR20110030688A (ko) 2008-07-15 2011-03-23 바스프 코포레이션 비세포독성 이산화염소 유체
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US20100203165A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US20100028266A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development. Inc. Composition and methods for treating allergic response
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20100196512A1 (en) 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
TW201105369A (en) * 2009-05-29 2011-02-16 Alcon Res Ltd N-halamine formulations with enhanced antimicrobial activity
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
US8992831B2 (en) 2009-09-25 2015-03-31 E. I. Du Pont De Nemours And Company Stabilized chlorine dioxide to preserve carbohydrate feedstocks
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
CA2782872A1 (en) * 2009-12-17 2011-06-23 Alpha Synergy Development, Inc. Compositions and methods for ophthalmic delivery of nasal decongestants
AU2011231543B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
BR112012024476A2 (pt) 2010-03-26 2017-03-01 Galderma Res & Dev método para fornecer um tratamento seguro e efetivo da telangiectasia e método de produzir um produto embalado
ES2585847T3 (es) 2010-06-30 2016-10-10 Galderma Research & Development Utilización de un agonista del receptor adrenérgico alfa para prevenir o tratar un tumor de la piel
CA2810746A1 (en) 2010-06-30 2012-01-05 Galderma Research & Development Method for preventing or treating skin tumor
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
RU2571277C2 (ru) 2010-10-21 2015-12-20 Галдерма С.А. Композиции геля с бримонидином и способы применения
US8445526B2 (en) 2011-02-03 2013-05-21 Glaucoma & Nasal Therapies Llc Compositions and methods for treatment of glaucoma
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
CA2850277A1 (en) 2011-10-19 2013-04-25 Galderma S.A. Method for treating capillary hemangiomas
WO2014074605A1 (en) * 2012-11-08 2014-05-15 Allergan, Inc. Preserved topical formulations with improved antimicrobial activity
US20150031712A1 (en) * 2013-03-12 2015-01-29 Moshe Rogosnitzky Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same
US8999938B2 (en) 2013-06-21 2015-04-07 Gnt Llc Ophthalmic lipophilic drug delivery vehicle formulations
JP6453318B2 (ja) 2013-09-26 2019-01-16 ガルデルマ ソシエテ アノニム 委縮性皮膚瘢痕を治療するためのプロスタグランジンＦ２α及びその類似体
UA117768C2 (uk) 2013-12-24 2018-09-25 Сентісс Фарма Прайвет Лімітед Офтальмологічний розчин тартрату бримонідину для місцевого застосування
CN107427460A (zh) * 2015-03-19 2017-12-01 阿勒根公司 溴莫尼定和噻吗洛尔的固定剂量组合
WO2017210454A1 (en) * 2016-06-03 2017-12-07 The Regents Of The University Of Colorado, A Body Corporate Ophthalmic disinfecting agent and methods of using the same
CN106265797A (zh) * 2016-09-18 2017-01-04 成都测迪森生物科技有限公司 一种洗眼液
CN108310442B (zh) * 2017-01-17 2021-08-27 台北科技大学 眼科用组合物
GR1009419B (el) 2017-11-07 2018-12-14 Φαρματεν Αβεε Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
HRP20220762T1 (hr) 2018-04-24 2022-09-16 Allergan, Inc. Upotreba pilokarpin-hidroklorida u liječenju prezbiopije
JP7490570B2 (ja) 2018-04-27 2024-05-27 アラーガン、インコーポレイテッド 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物
US11077053B2 (en) 2018-08-21 2021-08-03 Allergan, Inc. Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
US20230218611A1 (en) 2020-04-29 2023-07-13 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of brinzolamide and brimonidine
CN113419360A (zh) * 2021-06-23 2021-09-21 武汉爱尔眼科汉口医院有限公司 角膜塑形镜试戴片污染状况调查与干预措施
CN116135021A (zh) * 2021-11-17 2023-05-19 陈力瑜 杀菌组成物

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123521A (en) * 1964-03-03
USRE23218E (en) * 1945-02-21 1950-04-11 Catalytic bleaching with chlorites
US2436134A (en) * 1945-03-12 1948-02-17 Mathieson Alkali Works Inc Production of chlorine dioxide
US3278447A (en) * 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
US3591515A (en) * 1968-04-16 1971-07-06 Int Dioxide Inc Pulverulent chlorine dioxide compositions
GB1269677A (en) * 1969-12-11 1972-04-06 Procter & Gamble Ltd Bleaching composition
US3819828A (en) * 1973-02-16 1974-06-25 Procter & Gamble Anhydrous hair treating product containing a monopersulfate salt
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
US4123376A (en) * 1973-08-24 1978-10-31 Colgate-Palmolive Company Peroxymonosulfate-base bleaching and bleaching detergent compositions
GB1579431A (en) * 1976-03-23 1980-11-19 Minnesota Mining & Mfg Disinfecting and/or sterilising
US4084747A (en) * 1976-03-26 1978-04-18 Howard Alliger Germ killing composition and method
JPS596915B2 (ja) * 1980-05-13 1984-02-15 日本カ−リツト株式会社 二酸化塩素の電解製造方法
US4499077A (en) * 1981-02-03 1985-02-12 Stockel Richard F Anti-microbial compositions and associated methods for preparing the same and for the disinfecting of various objects
US4459217A (en) * 1981-07-22 1984-07-10 Reckitt & Colman Products Limited Denture cleansing compositions
US4654208A (en) * 1983-03-01 1987-03-31 Stockel Richard F Anti-microbial compositions comprising an aqueous solution of a germicidal polymeric nitrogen compound and a potentiating oxidizing agent
GB2139260B (en) * 1983-05-04 1986-09-03 Unilever Plc Bleaching and cleaning composition
US4568517A (en) * 1983-08-25 1986-02-04 Barnes-Hind, Inc. Disinfection of contact lenses
US4614549A (en) * 1983-10-24 1986-09-30 Bausch & Lomb Incorporated Method for enzymatic cleaning and disinfecting contact lenses
US4690773A (en) * 1983-10-24 1987-09-01 Bausch & Lomb Incorporated Microbial enzymatic contact lens cleaner and methods of use
IN160430B (da) * 1984-03-18 1987-07-11 Alcide Corp
US4613332A (en) * 1984-07-11 1986-09-23 The Clorox Company Controlled generation hypochlorite compositions and method
US4855135A (en) * 1984-07-30 1989-08-08 Ratcliff Perry A Method for debriding
US4793989A (en) * 1984-07-30 1988-12-27 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4837009A (en) * 1986-03-31 1989-06-06 Ratcliff Perry A Method and composition for prevention of plaque formation and plaque dependent diseases
US4696811A (en) * 1984-07-30 1987-09-29 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4689215A (en) * 1984-07-30 1987-08-25 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4788053A (en) * 1984-07-30 1988-11-29 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4618444A (en) * 1984-09-17 1986-10-21 Purex Corporation Household laundry detergent with dual strength bleach
GB8507678D0 (en) * 1985-03-25 1985-05-01 Univ Bath Cleaning/disinfection of contact lenses
EP0196075B1 (en) * 1985-03-26 1990-03-14 Toray Industries, Inc. Cleaning system for contact lenses and process for cleaning the same
GB8508010D0 (en) * 1985-03-27 1985-05-01 Unilever Plc Liquid bleaching compositions
USRE32672E (en) * 1985-09-09 1988-05-24 Allergan, Inc. Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme
GB2187748A (en) * 1986-03-07 1987-09-16 Unilever Plc Bleaching fabrics
US4786492A (en) * 1986-03-31 1988-11-22 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4851213A (en) * 1986-03-31 1989-07-25 Ratcliff Perry A Method and composition for prevention and treatment of oral disease due to S. Sanguis
DE3704823A1 (de) * 1987-02-16 1988-09-15 Thilo & Co Gmbh Dr Kontaktlinsenpflegemittel mit desinfizierender und reinigender wirkung
JPH0678769B2 (ja) * 1987-04-13 1994-10-05 石川島播磨重工業株式会社 セラミック軸受取付構造

Also Published As

Publication number Publication date
NO894740L (no) 1990-05-30
CA2003198C (en) 1995-03-21
CA2003198A1 (en) 1990-05-29
ATE147230T1 (de) 1997-01-15
FI895700A0 (fi) 1989-11-28
IE81090B1 (en) 2000-03-08
PT92453B (pt) 1995-07-18
DK593989D0 (da) 1989-11-24
AU4549989A (en) 1990-06-07
HUT52706A (en) 1990-08-28
CN1055874A (zh) 1991-11-06
HK1005164A1 (en) 1998-12-24
IL92351A (en) 1994-02-27
DE68927631D1 (de) 1997-02-20
EP0371728B1 (en) 1997-01-08
JPH02184631A (ja) 1990-07-19
HU206455B (en) 1992-11-30
PT92453A (pt) 1990-05-31
NZ231458A (en) 1992-01-29
DK593989A (da) 1990-05-30
JP2820744B2 (ja) 1998-11-05
IE893780L (en) 1990-05-29
KR900007427A (ko) 1990-06-01
IL92351A0 (en) 1990-07-26
ES2098226T3 (es) 1997-05-01
KR0160443B1 (ko) 1998-12-01
HU896225D0 (en) 1990-02-28
US5424078A (en) 1995-06-13
EP0371728A1 (en) 1990-06-06
DE68927631T2 (de) 1997-08-21
NO894740D0 (no) 1989-11-28
AU621689B2 (en) 1992-03-19

Similar Documents

Publication Publication Date Title
HUT52706A (en) Aqueous ophthalmic solutions and method for preserving same
NZ219633A (en) Extended release solid preparation
EP0511430A3 (en) Cell preservative solution
MX9603918A (es) Composicion oftalmica con viscosidad disminuida.
KR930001914A (ko) 안정화된 pvp-i 용액
IT1273011B (it) Preparato oftalmico per l'uso come lacrima artificiale
WO2002026277A3 (en) Stabilized hydrogen peroxide solutions
AU4888990A (en) High salt content rapid disinfection solution for contact lenses
KR900002789A (ko) 안과용 용액을 보존하는 방법 및 이를 위한 조성물
ATE268590T1 (de) Pharmazeutische emulsion enthaltend sorbinsäure, na-edta und borsäure
NL191879C (nl) Samenstelling voor het verlagen van de intra-oculaire druk.
HK1028738A1 (en) Water soluble dry compositions
TW255822B (da)
JPS5762218A (en) Ophthalmic solution
EP0356367A3 (en) Liquid medium for infusion and preservation of organs
DK0419165T3 (da) Konserveringsmiddel til anvendelse i ophthalmiske opløsninger
GR3005100T3 (da)
AU9095291A (en) Sterilising composition
GR3003690T3 (da)
DE68905796D1 (de) Chromoglycinsaeure-natriumsalz enthaltende aerosolzubereitungen.